CAS: 1192362-32-5 (dawb Peptide) DOTA-LM3 TFA

Xa kev nug
CAS: 1192362-32-5 (dawb Peptide) DOTA-LM3 TFA
Paub meej
CAS: 1192362-32-5 (tsis pub peptide)
Cov qauv tseem ceeb: Conjugate ntawm kev xaiv SSTR2 antagonist peptide LM3 thiab DOTA macrocyclic chelator. LM3 tsim ib qho kev ruaj khov cyclic active qauv ntawm ib daim ntawv cog lus intramolecular disulfide, nrog kev hloov kho chlorophenylalanine los txhim kho receptor affinity. TFA ntsev daim ntawv txhim kho purification efficiency thiab formulation stability. DOTA tuaj yeem ua tau zoo chelate radioactive hlau nuclides xws li ⁶⁸Ga thiab ¹⁷⁷Lu, combining ob hom phiaj paub thiab radionuclide loading zog.
Peb kuj muab cov lus qhia tshwj xeeb los ntawm crude mus rau 99% purity, thov hu rau peb kom paub meej!
** Cov ntaub ntawv ntsig txog **
COA/MS/HPLC Report
Peptide Dissolution thiab Cia Phau Ntawv Qhia
Radiolabeling Phau Ntawv Qhia
Kev faib tawm yam khoom
Pharmaceutical Peptides
Share to
Hauj lwm lawm

Shanghai Sonyt Biotechnology Co., Ltd. yog ib qho ntawm cov ua lag luam thiab cov chaw muag khoom ntawm cas: 1192362-32-5 (dawb peptide) dota-lm3 tfa hauv Suav teb, kuj txhawb kev pabcuam kev cai. Txais tos rau cov lag luam wholesale bulk zoo cas: 1192362-32-5 (dawb peptide) dota-lm3 tfa los ntawm peb lub hoobkas. Tiv tauj peb kom paub meej ntxiv.

 

Khoom npe DOTA-LM3 TFA
Kev piav qhia DOTA-LM3 yog ib qho kev xaiv zoo heev somatostatin receptor 2 (SSTR2) antagonist-raws li radionuclide conjugate peptide, covalently txuas los ntawm SSTR2 antagonist peptide LM3 thiab macrocyclic chelator DOTA. Lub LM3 moiety tshwj xeeb khi rau SSTR2 receptors tau nthuav tawm heev ntawm cov qog cell nto nrog nanomolar affinity, thiab tsis induce receptor internalization, tso cai rau khi rau ntau qhov chaw receptor. Lub DOTA macrocycle tuaj yeem ruaj khov chelate ntau yam xov tooj cua hlau nuclides xws li ⁶⁸Ga, ¹⁷⁷Lu thiab ⁹⁰Y nyob rau hauv cov mob me me, txhawb nqa ob qho tib si PET duab thiab cov phiaj xwm kev kho mob radionuclide. Piv nrog rau agonist-hom somatostatin peptides, nws cov cuab yeej antagonist txhim kho cov teeb liab- rau- suab nrov piv ntawm qog cov duab thiab kho tau zoo. Nws yog cov cuab yeej tseem ceeb rau kev tshawb fawb theranostics ntawm SSTR- cov qog zoo.
Peptide Purity (HPLC, %) 95% / 98% / 99%
Dawb puag molecular mis C₆₉H₉₃ClN₁₆O₁₉S₂
Dawb puag molecular hnyav (Da) 1550.16, siab dua rau TFA ntsev daim ntawv
Hom qauv Cyclic peptide-chelator conjugate, ib khub ntawm intramolecular disulfide bonds, DOTA macrocyclic chelating pawg, trifluoroacetate ntsev

 

Product Basic Information Table

 

Khoom Lub Npe Lus Askiv Product Abbreviation / Alias Function Tags (comma-sib cais) Core Structure Molecular Formula Exact Mass (Da) Qhov nruab nrab MW (Da) Daim ntawv ntsev Ntev (aa)
DOTA-LM3 TFA DOTA-LM3 trifluoroacetate; SSTR2 antagonist chelate Kev xaiv ntau yam SSTR2 antagonist, radionuclide chelation, neuroendocrine qog imaging, tsom radionuclide kho Cyclic peptide LM3 conjugated rau DOTA macrocyclic chelator ntawm tus linker; LM3 tsim ib lub voj voog ruaj khov ntawm ib daim ntawv cog lus intramolecular disulfide, nrog kev hloov kho chlorophenylalanine los txhim kho affinity; DOTA chelates ntau nuclides xws li ⁶⁸Ga thiab ¹⁷⁷Lu; TFA ntsev txhim kho kev ua kom huv huv Dawb peptide: C₆₉H₉₃ClN₁₆O₁₉S₂ 1549.62 1550.16 Trifluoroacetate (TFA) 8

Physicochemical Solubility & Cia Parameters

 

Khoom Code Qhov tshwm sim Ntev - Lub Sij Hawm Cia Luv - Lub Sij Hawm Cia Kev daws teeb meem Khoom hmoov ruaj khov
PEB-DLM002 hmoov dawb Khaws ntawm -20 degree, kaw, qhuav thiab tiv thaiv los ntawm lub teeb. Aliquot rau cia. Ua nruj ua tsiv kom tsis txhob muaj zog txo cov neeg ua haujlwm thiab tsis muaj cov hlau hnyav hnyav. ruaj khov rau 1 lub hlis ntawm 2-8℃nyob rau hauv kaw qhuav; nkoj ntawm cov pob khov nab kuab pom zoo. ruaj khov rau 7 hnub ntawm 4 degree. Dawb soluble hauv DMSO thiab DMF; me ntsis solubility nyob rau hauv physiological buffers, me ntsis txhim kho nyob rau hauv acidic tej yam kev mob. Disulfide daim ntawv cog lus tau nrawm nrawm los ntawm cov neeg ua haujlwm txo qis. Tsis txhob chelation ntxov ntxov ntawm NOTA pawg nrog dawb hlau ions. ruaj khov rau 3 xyoos ntawm -20 degree, qhuav thiab tiv thaiv los ntawm lub teeb.

Functional Description

 

Khoom Code Frontend Short Summary (rau cov npe tshawb nrhiav) Cov lus piav qhia txog kev ua haujlwm lom neeg lom neeg Cov cheeb tsam tshawb fawb (comma- cais) Lub Hom Phiaj / Txoj Kev
PEB-DLM002 Kev xaiv ntau yam SSTR2 antagonist chelate peptide rau radionuclide imaging thiab tsom txoj kev kho DOTA-LM3 yog ib qho kev xaiv zoo heev somatostatin receptor 2 (SSTR2) antagonist-raws li radionuclide conjugate peptide, covalently txuas los ntawm SSTR2 antagonist peptide LM3 thiab macrocyclic chelator DOTA. Lub LM3 moiety tshwj xeeb khi rau SSTR2 receptors tau nthuav tawm heev ntawm cov qog cell nto nrog nanomolar affinity, thiab tsis induce receptor internalization, tso cai rau khi rau ntau qhov chaw receptor. Lub DOTA macrocycle tuaj yeem ruaj khov chelate ntau yam xov tooj cua hlau nuclides xws li ⁶⁸Ga, ¹⁷⁷Lu thiab ⁹⁰Y nyob rau hauv cov mob me me, txhawb nqa ob qho tib si PET duab thiab cov phiaj xwm kev kho mob radionuclide. Piv nrog rau agonist-hom somatostatin peptides, nws cov cuab yeej antagonist txhim kho cov teeb liab- rau- suab nrov piv ntawm qog cov duab thiab kho tau zoo. Nws yog cov cuab yeej tseem ceeb rau kev tshawb fawb theranostics ntawm SSTR- cov qog zoo. Neuroendocrine qog kev tshawb fawb, kev tshawb fawb txog tshuaj nuclear kev tshawb fawb, tsom rau kev tshawb fawb radionuclide, kev tshawb fawb somatostatin receptor function, peptide-kev txhim kho tshuaj conjugate Somatostatin receptor 2 (SSTR2); DOTA chelating pawg / radionuclide cab kuj

 

 

 

 

 

 

 

 

 

Cim npe nrov: cas: 1192362-32-5 (dawb peptide) dota-lm3 tfa, Tuam Tshoj cas: 1192362-32-5 (dawb peptide) dota-lm3 tfa manufacturers, lwm tus neeg, Hoobkas

Xa kev nug